Design, implementation, and evaluation at entry of a prospective cohort study of homosexual and bisexual HIV-1-negative men in Belo Horizonte, Brazil: Project Horizonte

被引:16
作者
Carneiro, M
Antunes, CMD
Greco, M
Oliveira, E
Andrade, J
Lignani, L
Greco, DB
机构
[1] Univ Fed Minas Gerais, DIP, Fac Med,Dept Clin Med, Serv Doencas Infecciosas & Parasitarias, BR-30130100 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Med Trop, BR-30130100 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30130100 Belo Horizonte, MG, Brazil
[4] Santa Casa Misericordia Belo Horizonte, Belo Horizonte, MG, Brazil
关键词
HIV; HIV incidence; homosexual and bisexual; open cohort; vaccines;
D O I
10.1097/00126334-200010010-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background and Objectives: Project Horizonte, an open cohort of homosexual and bisexual HIV-l-negative men, is a component of the Minas Gerais AIDS Vaccine Program of the Federal University of Minas Gerais, Belo Horizonte, Brazil. Its objectives included the evaluation of seroincidence of HIV, to ascertain the role of counseling on behavior modification and to assess their willingness to participate in future HIV vaccine trials. Methods: Various means of recruitment were used, including pamphlets, notices in community newspapers, radio, and television, at anonymous testing centers;, and by word of mouth. Results: From October 1994 to May 1999, 470 volunteers were enrolled, Their mean age was 26 years and over 70% of them had high school or college education. During the follow-up, they were seen every 6 months, when they received counseling and condoms, and when HIV testing was done. Eighteen seroconversions were observed, and the incidence rates estimates were 1.75 per 100 and 1.99 per 100 person years, for 36 and 48 months of follow-up, respectively. During the entire period, 139 volunteers were lost to follow-up. Among them, 59 (42.4%) never returned after the initial visit and 51 (36.7) came only once after their initial visit. No losses were observed for those observed during follow-up for more than 3 years. At enrollment, 50% of participants said they would participate in a vaccine trial, and 30% said they might participate. Conclusions: The results obtained up to this moment confirm the feasibility of following this type of cohort for an extended period, estimating HIV incidence rate, and evaluating counseling for safe sexual practices in preparation for clinical trials with candidate HIV vaccines in Brazil.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 21 条
[1]  
ANDRADE J, 1996, 11 INT C AIDS VANC B
[2]   Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men [J].
Bartholow, BN ;
MacQueen, KM ;
Douglas, JM ;
Buchbinder, S ;
McKirnan, D ;
Judson, FN .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (02) :108-115
[3]  
BRETA MBA, 1996, 11 INT C AIDS VANC B
[4]  
BRUNDAGE JF, 1990, J ACQ IMMUN DEF SYND, V3, P1168
[5]   Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate [J].
Buchbinder, SP ;
Douglas, JM ;
McKirnan, DJ ;
Judson, FN ;
Katz, MH ;
MacQueen, KM .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :954-961
[6]  
CARNEIRO M, 1996, 11 INT C AIDS VANC B
[7]   THE MULTICENTER AIDS COHORT STUDY - RETENTION AFTER 9-1/2 YEARS [J].
DUDLEY, J ;
JIN, S ;
HOOVER, D ;
METZ, S ;
THACKERAY, R ;
CHMIEL, J .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (03) :323-330
[8]  
FONSECA JJ, 1996, 11 INT C AIDS VANC B
[9]  
GRECO DB, 1998, 12 INT C AIDS GEN SW
[10]  
GRECO M, 1998, 12 INT C AIDS GEN SW